Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
Medicaid expansion saves lives and saves money, proponents said — an estimated $27 million the last biennium, according to Rep. Ed Buttrey, sponsoring one bill to continue the program. “Our program is ...
The safety analysis set included all patients who received ≥1 dose of any study drug. The primary end point of OS was defined as time from random assignment to death due to any cause. A target sample ...